Show simple item record

FieldValueLanguage
dc.contributor.authorDrabarek, Dorothy
dc.contributor.authorHabgood, Emily
dc.contributor.authorJanda, Monika
dc.contributor.authorHersch, Jolyn
dc.contributor.authorAckermann, Deonna M
dc.contributor.authorLow, Don
dc.contributor.authorLow, Cynthia
dc.contributor.authorMorton, Rachael L
dc.contributor.authorDieng, Mbatho
dc.contributor.authorCust, Anne E
dc.contributor.authorMorgan, Adelaide
dc.contributor.authorSmith, Elloise
dc.contributor.authorBell, Katy J.L.
dc.date.accessioned2023-02-21T22:45:41Z
dc.date.available2023-02-21T22:45:41Z
dc.date.issued2022en
dc.identifier.urihttps://hdl.handle.net/2123/30081
dc.description.abstractCurrent clinician-led melanoma surveillance models require frequent routinely scheduled clinic visits, with associated travel, cost, and time burden for patients. Patient-led surveillance is a new model of follow-up care that could reduce health care use such as clinic visits and medical procedures and their associated costs, increase access to care, and promote early diagnosis of a subsequent new melanoma after treatment of a primary melanoma. Understanding patient experiences may allow improvements in implementation. Objective: This study aims to explore patients’ experiences and perceptions of patient-led surveillance during the 6 months of participation in the MEL-SELF pilot randomized controlled trial. Patient-led surveillance comprised regular skin self-examination, use of a mobile dermatoscope to image lesions of concern, and a smartphone app to track and send images to a teledermatologist for review, in addition to usual care. Methods: Semistructured interviews were conducted with patients previously treated for melanoma localized to the skin in New South Wales, Australia, who were randomized to the patient-led surveillance (intervention group) in the trial. Thematic analysis was used to analyze the data with reference to the technology acceptance model. Results: We interviewed 20 patients (n=8, 40% women and n=12, 60% men; median age 62 years). Patients who were more adherent experienced benefits such as increased awareness of their skin and improved skin self-examination practice, early detection of melanomas, and opportunities to be proactive in managing their clinical follow-up. Most participants experienced difficulty in obtaining clear images and technical problems with the app. These barriers were overcome or persevered by participants with previous experience with digital technology and with effective help from a skin check partner (such as a spouse, sibling, or friend). Having too many or too few moles decreased perceived usefulness.en
dc.language.isoenen
dc.publisherJMIR Publicationsen
dc.relation.ispartofJMIR Dermatologyen
dc.rightsCreative Commons Attribution 4.0en
dc.subjectmelanomaen
dc.subjectself-surveillanceen
dc.subjectdigital technologiesen
dc.subjectteledermoscopyen
dc.subjectteledermatologyen
dc.subjectmHealthen
dc.subjectmobile phoneen
dc.titleExperiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Studyen
dc.typeArticleen
dc.subject.asrc1112 Oncology and Carcinogenesisen
dc.subject.asrc1117 Public Health and Health Servicesen
dc.identifier.doi10.2196/35916
dc.type.pubtypePublisher's versionen
dc.relation.nhmrc1163054
dc.relation.nhmrc1194703
dc.relation.nhmrc1151021
dc.relation.nhmrc1112509
dc.relation.nhmrc2008454
dc.relation.nhmrc1174523
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Healthen
usyd.citation.volume5en
usyd.citation.issue3en
workflow.metadata.onlyNoen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.